{"title":"Advancing Biomedical Engineering With Artificial Intelligence and Machine Learning: A Systematic Review","authors":"Abebe Belay Adege","doi":"10.1155/ijcp/9888902","DOIUrl":null,"url":null,"abstract":"<div>\n <p>The inclusion of artificial intelligence (AI) and machine learning (ML) in biomedical engineering opens new frontiers of innovation and better decision-making and allows the art to cross new thresholds in healthcare technologies. This review focuses on the primary contributions of AI and ML to the advancement of biomedical engineering, particularly in the areas of diagnostic tools, predictive analytics, and personalized medicine. This will further allow us to identify possible the state-of-the-art solutions by using new frameworks for applications including medical imaging, wearables, and biomanufacturing. Also, it reflects on how ethics in AI and ML for biomedical challenges address important issues such as bias, privacy, and accountability. It also underlines how different opportunities and challenges can be opened or addressed by the integration of AI-driven systems in biomedical workflows: engineering, clinicians, and data scientists have to cooperate. Emerging technologies, including but not limited to deep learning, natural language processing, and reinforcement learning, are discussed for their potential to alter biomedical research and clinical practice. The work concludes with a look at the future of biomedical engineering, where AI and ML have brought a domain of synergy into innovation, better patient outcomes, and impactful advancement. It thus also provides a prescription for the need for ethics in the adoption of AI, together with collaborative efforts toward maximum transformative technology.</p>\n </div>","PeriodicalId":13782,"journal":{"name":"International Journal of Clinical Practice","volume":"2025 1","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ijcp/9888902","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/ijcp/9888902","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
The inclusion of artificial intelligence (AI) and machine learning (ML) in biomedical engineering opens new frontiers of innovation and better decision-making and allows the art to cross new thresholds in healthcare technologies. This review focuses on the primary contributions of AI and ML to the advancement of biomedical engineering, particularly in the areas of diagnostic tools, predictive analytics, and personalized medicine. This will further allow us to identify possible the state-of-the-art solutions by using new frameworks for applications including medical imaging, wearables, and biomanufacturing. Also, it reflects on how ethics in AI and ML for biomedical challenges address important issues such as bias, privacy, and accountability. It also underlines how different opportunities and challenges can be opened or addressed by the integration of AI-driven systems in biomedical workflows: engineering, clinicians, and data scientists have to cooperate. Emerging technologies, including but not limited to deep learning, natural language processing, and reinforcement learning, are discussed for their potential to alter biomedical research and clinical practice. The work concludes with a look at the future of biomedical engineering, where AI and ML have brought a domain of synergy into innovation, better patient outcomes, and impactful advancement. It thus also provides a prescription for the need for ethics in the adoption of AI, together with collaborative efforts toward maximum transformative technology.
期刊介绍:
IJCP is a general medical journal. IJCP gives special priority to work that has international appeal.
IJCP publishes:
Editorials. IJCP Editorials are commissioned. [Peer reviewed at the editor''s discretion]
Perspectives. Most IJCP Perspectives are commissioned. Example. [Peer reviewed at the editor''s discretion]
Study design and interpretation. Example. [Always peer reviewed]
Original data from clinical investigations. In particular: Primary research papers from RCTs, observational studies, epidemiological studies; pre-specified sub-analyses; pooled analyses. [Always peer reviewed]
Meta-analyses. [Always peer reviewed]
Systematic reviews. From October 2009, special priority will be given to systematic reviews. [Always peer reviewed]
Non-systematic/narrative reviews. From October 2009, reviews that are not systematic will be considered only if they include a discrete Methods section that must explicitly describe the authors'' approach. Special priority will, however, be given to systematic reviews. [Always peer reviewed]
''How to…'' papers. Example. [Always peer reviewed]
Consensus statements. [Always peer reviewed] Short reports. [Always peer reviewed]
Letters. [Peer reviewed at the editor''s discretion]
International scope
IJCP publishes work from investigators globally. Around 30% of IJCP articles list an author from the UK. Around 30% of IJCP articles list an author from the USA or Canada. Around 45% of IJCP articles list an author from a European country that is not the UK. Around 15% of articles published in IJCP list an author from a country in the Asia-Pacific region.